Obesity, plasma high sensitivity c-reactive protein levels and insulin resistance status among school children in Taiwan

Clinical Biochemistry

Volumn 39, Issue 8, 2006, Pages 810-815

  Wu, Der Min ^a   Chu, Nain Feng ^b   Shen, Muh Han ^a   Wang, Shu Chuan ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

C reactive protein; Children; Insulin resistance; Obesity

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; TRIACYLGLYCEROL;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRINKING; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NEPHELOMETRY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SAMPLING; SCHOOL CHILD; SMOKING; STANDARD; SYSTOLIC BLOOD PRESSURE; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; TAIWAN;

EID: 33747148871     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.05.007     Document Type: Article

References (34)

1. Steel D.M., and Whitehead A.S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15 (1994) 81-88
2. Danesh J., Collins R., Appleby P., and Peto R. Fibrinogen, C-reactive protein, albumin or white cell count: meta-analyses of prospective studies of coronary heart disease. JAMA 79 (1998) 1477-1482
3. Ridker P.M., Rifai N., Pfeffer M.A., Sacks F.M., and Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 100 (1999) 230-235
4. Mendall M.A., Patel P., Ballam L., Strachan D., and Northfield T.C. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br Med J 312 (1996) 1061-1065
5. Rohde L.E., Hennekens C.H., and Ridker P.M. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 84 (1999) 1018-1022
6. Tracy R.P., Lemaitre R.N., Pasty B.M., Ives D.G., Evans R.W., Cushman M., et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17 (1997) 1121-1127
7. Palosuo T., Husman T., Koistinen J., and Aho K. C-reactive protein in population samples. Acta Med Scand 220 (1986) 175-179
8. Alvarez C., and Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem 32 (1986) 142-145
9. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., and Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 (1999) 2131-2135
10. Ford E.S. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22 (1999) 1971-1977
11. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., and Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disability Angina Pectoris Study Group. Lancet 349 (1997) 462-466
12. Ridker P.M., Glynn R.J., and Hennekens C.H. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97 (1998) 2007-2011
13. Lagrand W.K., Visser C.A., Hermens W.T., Niessen H.W., Verheugt F.W., Wolbink G.J., et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?. Circulation 100 (1999) 96-102
14. Cook D.G., Mendall M.A., Whincup P.H., Carey I.M., Ballam L., Morris J.E., et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 149 (2000) 139-150
15. Ford E.S., Galuska D.A., Gillespie C., Will J.C., Giles W.H., and Dietz W.H. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr 138 (2001) 486-492
16. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., and Harris T.B. Low-grade systemic inflammation in overweight children. Pediatrics 107 (2001) E13
17. Weiss R., Dziura J., Burgert T.S., Tamborlane W.V., Taksali S.E., Yeckel C.W., et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350 (2004) 2362-2374
18. Chu N.F., Rimm E.B., Wang D.J., Liou H.S., and Shieh S.M. Relationship between anthropometric variable and lipid levels among school children: the Taipei Children Heart Study. Int J Obes 22 (1998) 66-72
19. Chu N.F., Rimm E.B., Wang D.J., Liou H.S., and Shieh S.M. Clustering of cardiovascular disease risk factors among obese schoolchildren: The Taipei Children Heart Study. Am J Clin Nutr 67 (1998) 1141-1146
20. Kadish A.H., Litle R.L., and Sternberg J.C. A new and rapid method for determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14 (1968) 116-131
21. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19 (1973) 1350-1356
22. Stavropoulos W.S., and Crouch R.D. A new calorimetric procedure for the determination of serum triglyceride. Clin Chem 20 (1974) 857
23. Wamick G.R., Benderson J., and Albers J.J. Dextran sulfate-Mg precipitation procedure for quantification of high density lipoprotein-cholesterol. Clin Chem 28 (1982) 1379-1388
24. Robert W.L., Sedrick R., Moulton L., Spencer A., and Firai N. Evaluation of four automated high sensitivity C-reactive protein method: implications for clinical and epidemiological applications. Clin Chem 46 (2000) 461-468
25. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
26. Chu N.F., Wang D.J., Shieh S.M., and Rimm E.B. Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in Taiwan-The Taipei Children Heart Study. Int J Obes Relat Meta Disord 24 (2000) 1265-1271
27. Castell J.V., Andus T., Kunz D., and Heinrich P.C. Interleukin-6: the major regulator of acute-phase protein synthesis in man and rat. Ann N Y Acad Sci 557 (1989) 87-101
28. Neumann F.J., Ott I., Gawaz M., Richardt G., Holzapfel H., Jochum M., et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infraction. Circulation 92 (1995) 748-755
29. Gauldie J., Richards C., Northemann W., Fey G., and Baumann H. IFNb2/BSF/IL-6 is the monocyte-derived HSF that regulates receptor specific acute phase gene regulation in hepatocytes. Ann N Y Acad Sci 557 (1989) 46-59
30. Agrawal A., Kilpatrick J.M., and Volanakis J.E. Structure and function of human C-reactive protein. In: Mackiewicz A., Kushner I., and Baumann H. (Eds). Acute phase proteins. Molecular biology, biochemistry, and clinical applications (1993), CRC Press, Inc., Boca Raton, Fla. 79-92
31. Baumann H., and Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 7 (1990) 147-159
32. Banks R.E., Forbes M.A., Storr M., Higginson J., Thompson D., Raynes J., et al. The acute phase response in patients receiving subcutaneous IL-6. Clin Exp Immunol 102 (1995) 217-223
33. Papanicolaou D.A., Wilder R.L., Manolagas S.C., and Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128 (1998) 127-137
34. Ford E.S., and Giles W.H. Serum C-reactive protein and self-reported stroke: finding from the Third National Health and Nutrition Examination Survey. Arterioscler Thromb Vasc Biol 20 (2000) 1052-1056